9 completed. 9 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 9 |
| Phase 2 | 2 | Completed 2 |
Follow testosterone enanthate: new trials by email Literature Review of testosterone enanthate trials Research Report on testosterone enanthate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Testosterone and rHGH in FSHD Testosterone Enanthate, Somatropin - Facioscapulohumeral Muscular Dystrophy | Phase 1 | Completed | University of Rochester | 20 | 2017-12-18 | 2023-05-16 |
| Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients Testosterone, Protein Supplement, Placebo Injection - Aging | Phase 1 | Completed | The University of Texas Medical Branch, Galveston | 80 | 2016-09-01 | 2024-12-17 |
| A Study to Evaluate a Skeletal-muscle Microbiopsy Technique With Dynamic Proteomic Measurement in Healthy Male Volunteers Deuterated Water, Testosterone enanthate, Placebo to match testosterone enanthate - Cachexia | Phase 1 | Completed | GlaxoSmithKline | 20 | 2014-05-05 | 2017-05-09 |
| Feasibility Study of Post-hospitalization Interventions to Improve Physical Function in Older Adults Placebo, Nutritional Supplement, In-home exercise - Aging | Phase 1 | Completed | The University of Texas Medical Branch, Galveston | 113 | 2013-10-01 | 2019-04-04 |
| Pharmacokinetic Study of Testosterone Enanthate QuickShot™ - 50 mg Treatment B, QuickShot™ - 100 mg Treatment A, Delatestryl 200 mg IM Treatment C - Hypogonadism | Phase 1 / Phase 2 | Completed | Antares Pharma Inc. | 39 | 2013-09-01 | 2018-01-11 |
| Testosterone for Treating Cachexia in Patients With Squamous Cell Carcinoma Placebo Testosterone, Testosterone Enanthate 100 MG/ML - Cachexia, Squamous Cell Carcinoma | Phase 1 | Completed | The University of Texas Medical Branch, Galveston | 28 | 2009-06-03 | 2018-03-12 |
| Safety and Tolerability of MK0773 in Healthy Older Men (0773-004) MK0773, Comparator: testosterone enanthate, Comparator: placebo oral tablet - Healthy | Phase 1 | Completed | Merck Sharp & Dohme LLC | 68 | 2007-06-01 | 2016-07-12 |
| Oral Androgens in Man-4: (Short Title: Oral T-4) Testosterone Enanthate, Dutasteride, placebo sesame oil - Contraception | Phase 1 / Phase 2 | Completed | University of Washington | 20 | 2006-11-01 | 2008-09-22 |
| Cycled Testosterone Replacement Study Testosterone, Placebo - Hypogonadism | Phase 1 | Completed | The University of Texas Medical Branch, Galveston | 26 | 2006-01-01 | 2012-09-10 |
Cachexia (2) · Hypogonadism (2) · Carcinoma, Squamous Cell (1) · Motor Activity (1) · Muscular Dystrophy, Facioscapulohumeral (1) · Uterine Cervical Neoplasms (1)
The University of Texas Medical Branch, Galveston (4) · Antares Pharma Inc. (1) · GlaxoSmithKline (1) · Merck Sharp & Dohme LLC (1) · University of Rochester (1) · University of Washington (1)
United States (8)
Elena Volpi, MD, PhD (2) · Chad R Heatwole, MD, MS-CI (1) · Gary Bedel, MD (1) · John K Amory, MD, MPH (1) · Melinda Sheffield-Moore, PhD (1) · Randall J Urban, M.D. (1)
PMID 18046048, PMID 28591764, PMID 30906944, PMID 31391011, PMID 37251511, PMID 40900971, PMID 41316872
K23HD045386 (1), R01AG022023 (1), R01CA127971 (1), U54HD042454 (1)